New sensor technology can detect life-threatening complications after intestinal surgery at an earlier stage
Peer-Reviewed Publication
Updates every hour. Last Updated: 16-Dec-2025 08:11 ET (16-Dec-2025 13:11 GMT/UTC)
An interdisciplinary research team from Dresden University of Technology (TUD), Rostock University Medical Centre (UMR) and Dresden University Hospital has developed an innovative, implantable and fully absorbable sensor film. For the first time, it enables reliable early detection of circulatory disorders in intestinal anastomoses – one of the riskiest surgical procedures in the abdominal cavity. The results have now been presented in the renowned journal ‘Advanced Science’.
Bonn, December 11, 2025 – Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of Bonn has discovered that these cells only survive because they activate a special antioxidant protection mechanism. When this mechanism is blocked, allergic inflammation in mouse models decreases significantly. The results have now been published in the scientific journal Immunity.
Researchers at Beijing Tiantan Hospital analyzed 101 glioma cases involving the brain’s motor pathway and found that one-third of patients developed permanent paralysis after surgery. High tumor grade, pre-operative motor deficits, and larger tumor volume were key predictors. The work underscores the need for precise imaging and careful surgical planning to maximize survival while safeguarding motor function.
A retrospective observational study found that valvular heart disease, detected by cardiovascular imaging, was common in patients with a previous cancer diagnosis. Interventions to treat valvular heart disease were infrequent; however, when performed, they significantly improved survival. These findings highlight the need to refer cancer patients for regular cardiovascular monitoring and also provide reassurance that interventions may be beneficial.
Alzheimer’s disease (AD) imposes a substantial clinical and societal burden, yet currently approved symptomatic therapies do not modify the underlying disease biology. Recently, three anti-amyloid monoclonal antibodies (aducanumab, lecanemab, and donanemab) have demonstrated robust amyloid clearance. Their clinical effects are statistically significant but modest, underscoring the need for broader, biologically informed strategies. Guided by the 2024 Alzheimer’s association ATNIVS biomarker framework, a team form Xuanwu Hospital, Capital Medical University synthesizes disease-modifying therapies (DMTs) targeting amyloid (A), tau (T), neurodegeneration (N), inflammation (I), vascular injury (V), and α-synuclein (S), summarizing the candidate therapies for each target, explain the mechanisms of action and pivotal clinical trial results. The review is currently published on the journal Medicine Plus.
The International Osteoporosis Foundation (IOF) and the Asia Pacific Consortium on Osteoporosis (APCO) have today launched The APCO-IOF Asia Pacific Regional Audit: Epidemiology, Costs and Burden of Osteoporosis In 2025. This key report presents the most comprehensive assessment to date of the burden of osteoporosis and fragility fractures across 22 countries and regions, revealing both the magnitude of the challenge and the opportunities for timely, collaborative action.
A multicenter study across Japan found that ICU patients receiving more intensive rehabilitation regained independence faster after critical illness. Among 121 patients on mechanical ventilation, higher rehabilitation dose and mobility levels were linked to a lower risk of delayed recovery. The findings highlight that purposeful, early mobilization can improve outcomes and shorten recovery for ICU survivors.